AbbVie Sues Medicaid, HHS Over Botox Fair Price Controls
By Hailey Konnath · February 11, 2026, 10:32 PM EST
AbbVie Inc. on Wednesday asked a D.C. federal court to block the Centers for Medicare and Medicaid Services from controlling the price of Botox under the Inflation Reduction Act, arguing the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login